Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection
Clinical trial NCT05213637 · UNKNOWN
Trial details
- NCT number
- NCT05213637
- Sponsor
- Chinese PLA General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2022-06-30
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.